These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29122712)

  • 81. Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles.
    Pradhan R; Poudel BK; Choi JY; Choi IS; Shin BS; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2015; 38(5):734-41. PubMed ID: 24824337
    [TBL] [Abstract][Full Text] [Related]  

  • 82. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
    Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
    J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayer.
    Xie J; Lei C; Hu Y; Gay GK; Bin Jamali NH; Wang CH
    Curr Pharm Des; 2010 Jul; 16(21):2331-40. PubMed ID: 20618154
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
    Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Development of a microparticulate system containing Brazilian propolis by-product and gelatine for ascorbic acid delivery: evaluation of intestinal cell viability and radical scavenging activity.
    de Francisco LMB; Pinto D; Rosseto HC; de Toledo LAS; Dos Santos RS; Costa P; Rodrigues F; Oliveira MBPP; Sarmento B; Bruschi ML
    Food Funct; 2018 Aug; 9(8):4194-4206. PubMed ID: 29993073
    [TBL] [Abstract][Full Text] [Related]  

  • 86. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
    Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
    Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.
    Fargnoli AS; Mu A; Katz MG; Williams RD; Margulies KB; Weiner DB; Yang S; Bridges CR
    J Transl Med; 2014 Jun; 12():171. PubMed ID: 24934216
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Widening the Therapeutic Perspectives of Clofazimine by Its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC
    Wankar J; Bonvicini F; Benkovics G; Marassi V; Malanga M; Fenyvesi E; Gentilomi GA; Reschiglian P; Roda B; Manet I
    Mol Pharm; 2018 Sep; 15(9):3823-3836. PubMed ID: 30024758
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization.
    Katara R; Sachdeva S; Majumdar DK
    Drug Deliv Transl Res; 2017 Oct; 7(5):632-641. PubMed ID: 28812225
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.
    Radwan SE; Sokar MS; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2017 Jun; 526(1-2):366-379. PubMed ID: 28487189
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain.
    Belletti D; Grabrucker AM; Pederzoli F; Menrath I; Vandelli MA; Tosi G; Duskey TJ; Forni F; Ruozi B
    Int J Pharm; 2018 May; 543(1-2):300-310. PubMed ID: 29608954
    [TBL] [Abstract][Full Text] [Related]  

  • 92. pH-sensitive nanoparticles for improved oral delivery of dapsone: risk assessment, design, optimization and characterization.
    Chaves LL; Costa Lima SA; Vieira AC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Nanomedicine (Lond); 2017 Aug; 12(16):1975-1990. PubMed ID: 28745104
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
    Campos Pacheco JE; Yalovenko T; Riaz A; Kotov N; Davids C; Persson A; Falkman P; Feiler A; Godaly G; Johnson CM; Ekström M; Pilkington GA; Valetti S
    J Control Release; 2024 May; 369():231-250. PubMed ID: 38479444
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery.
    Ismail R; Sovány T; Gácsi A; Ambrus R; Katona G; Imre N; Csóka I
    Pharm Res; 2019 May; 36(7):99. PubMed ID: 31087188
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Curdlan-Conjugated PLGA Nanoparticles Possess Macrophage Stimulant Activity and Drug Delivery Capabilities.
    Tukulula M; Hayeshi R; Fonteh P; Meyer D; Ndamase A; Madziva MT; Khumalo V; Labuschagne P; Naicker B; Swai H; Dube A
    Pharm Res; 2015 Aug; 32(8):2713-26. PubMed ID: 25724161
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis of hesperetin-loaded PLGA nanoparticles by two different experimental design methods and biological evaluation of optimized nanoparticles.
    Duranoğlu D; Uzunoglu D; Mansuroglu B; Arasoglu T; Derman S
    Nanotechnology; 2018 Sep; 29(39):395603. PubMed ID: 29972381
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption.
    Li Y; Yang B; Zhang X
    Int J Pharm; 2019 Sep; 568():118508. PubMed ID: 31299337
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Nanoparticle formulation of 11-keto-β-boswellic acid (KBA): anti-inflammatory activity and in vivo pharmacokinetics.
    Bairwa K; Jachak SM
    Pharm Biol; 2016 Dec; 54(12):2909-2916. PubMed ID: 27305832
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Polymeric nanoparticles as a platform for permeability enhancement of class III drug amikacin.
    Fatima S; Iqbal Z; Panda AK; Samim M; Talegaonkar S; Ahmad FJ
    Colloids Surf B Biointerfaces; 2018 Sep; 169():206-213. PubMed ID: 29778036
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cherry Extract from
    Beconcini D; Fabiano A; Di Stefano R; Macedo MH; Felice F; Zambito Y; Sarmento B
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.